105 related articles for article (PubMed ID: 23803374)
1. Serum liver fatty acid binding protein shows good correlation with liver histology in NASH.
Özenirler S; Degertekin CK; Erkan G; Elbeğ Ş; Tuncer C; Kandilc U; Akyol G
Hepatogastroenterology; 2013; 60(125):1095-100. PubMed ID: 23803374
[TBL] [Abstract][Full Text] [Related]
2. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and histological features of non-alcoholic fatty liver disease].
Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
[TBL] [Abstract][Full Text] [Related]
4. The relationship between advanced oxidation protein products (AOPP) and biochemical and histopathological findings in patients with nonalcoholic steatohepatitis.
Ozenirler S; Erkan G; Konca Degertekin C; Ercin U; Cengiz M; Bilgihan A; Yilmaz G; Akyol G
J Dig Dis; 2014 Mar; 15(3):131-6. PubMed ID: 24528633
[TBL] [Abstract][Full Text] [Related]
5. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.
Bahcecioglu IH; Yalniz M; Ataseven H; Ilhan N; Ozercan IH; Seckin D; Sahin K
Hepatogastroenterology; 2005; 52(65):1549-53. PubMed ID: 16201116
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic and anti-apoptotic seromarkers for assessment of disease severity of non-alcoholic steatohepatitis.
El Bassat H; Ziada DH; Hasby EA; Nagy H; Abo Ryia MH
Arab J Gastroenterol; 2014 Mar; 15(1):6-11. PubMed ID: 24630506
[TBL] [Abstract][Full Text] [Related]
7. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?
Chitturi S; Farrell G; Frost L; Kriketos A; Lin R; Fung C; Liddle C; Samarasinghe D; George J
Hepatology; 2002 Aug; 36(2):403-9. PubMed ID: 12143049
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.
Coulon S; Francque S; Colle I; Verrijken A; Blomme B; Heindryckx F; De Munter S; Prawitt J; Caron S; Staels B; Van Vlierberghe H; Van Gaal L; Geerts A
Cytokine; 2012 Aug; 59(2):442-9. PubMed ID: 22658783
[TBL] [Abstract][Full Text] [Related]
9. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
10. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis.
Koruk M; Tayşi S; Savaş MC; Yilmaz O; Akçay F; Karakök M
Turk J Gastroenterol; 2003 Mar; 14(1):12-7. PubMed ID: 14593532
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis.
Bechmann LP; Gieseler RK; Sowa JP; Kahraman A; Erhard J; Wedemeyer I; Emons B; Jochum C; Feldkamp T; Gerken G; Canbay A
Liver Int; 2010 Jul; 30(6):850-9. PubMed ID: 20408954
[TBL] [Abstract][Full Text] [Related]
13. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
Wong VW; Wong GL; Choi PC; Chan AW; Li MK; Chan HY; Chim AM; Yu J; Sung JJ; Chan HL
Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
[TBL] [Abstract][Full Text] [Related]
14. [Association between serum adipocyte fatty acid binding protein level and dyslipidemia in patients with obstructive sleep apnea syndrome].
Wang YB; Chen R; Zhang YL; Li J; Shen JC; Xiong KP; Liu CF
Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(2):94-7. PubMed ID: 22490689
[TBL] [Abstract][Full Text] [Related]
15. Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans.
Pihlajamäki J; Kuulasmaa T; Kaminska D; Simonen M; Kärjä V; Grönlund S; Käkelä P; Pääkkönen M; Kainulainen S; Punnonen K; Kuusisto J; Gylling H; Laakso M
J Hepatol; 2012 Mar; 56(3):663-70. PubMed ID: 22027586
[TBL] [Abstract][Full Text] [Related]
16. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
17. Is there a relationship between serum heart- type fatty acid binding protein level and clinical severity in patients with subarachnoid hemorrhage?
Yilman M; Cokluk C; Baydin A; Yardan T; Kati C; Gunay M; Meric M
Turk Neurosurg; 2012; 22(6):695-700. PubMed ID: 23208899
[TBL] [Abstract][Full Text] [Related]
18. Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores.
Senateş E; Colak Y; Yeşil A; Coşkunpinar E; Sahin O; Kahraman OT; Erkalma Şenateş B; Tuncer I
Minerva Med; 2012 Oct; 103(5):369-76. PubMed ID: 23042372
[TBL] [Abstract][Full Text] [Related]
19. Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels.
Tsutsui M; Tanaka N; Kawakubo M; Sheena Y; Horiuchi A; Komatsu M; Nagaya T; Joshita S; Umemura T; Ichijo T; Matsumoto A; Yoshizawa K; Aoyama T; Tanaka E; Sano K
J Clin Gastroenterol; 2010 Jul; 44(6):440-7. PubMed ID: 20104187
[TBL] [Abstract][Full Text] [Related]
20. Serum leptin levels in patients with nonalcoholic steatohepatitis.
Uygun A; Kadayifci A; Yesilova Z; Erdil A; Yaman H; Saka M; Deveci MS; Bagci S; Gulsen M; Karaeren N; Dagalp K
Am J Gastroenterol; 2000 Dec; 95(12):3584-9. PubMed ID: 11151896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]